Código 293629 (Harmonized System 2012 by 6 digits)
2023: US$29.9M, Total Trade Exchange
2023: US$1M, International Sales
2023: US$28.9M, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of Its Vitamins and Used Primarily as Vitamins, Unmixed Derivatives (Exc. Vitamins A, B1, B2, B3, B5, B6, B12, C, E, H and Derivatives) was US$29.9M.
In 2023, the states with the most international sales in Its Vitamins and Used Primarily as Vitamins, Unmixed Derivatives (Exc. Vitamins A, B1, B2, B3, B5, B6, B12, C, E, H and Derivatives) were Jalisco (US$674k) and Estado de México (US$591).
The states with the most international purchases in 2023 were Jalisco (US$21.4M), Ciudad de México (US$1.89M), Estado de México (US$1.87M), Querétaro (US$1.57M), and Nuevo León (US$1.07M).
In 2023, the main commercial destinations of Its Vitamins and Used Primarily as Vitamins, Unmixed Derivatives (Exc. Vitamins A, B1, B2, B3, B5, B6, B12, C, E, H and Derivatives) were Costa Rica (US$176k), Dominican Republic (US$151k), El Salvador (US$147k), Guatemala (US$87.4k), and Colombia (US$38.2k).
The main commercial origins of Its Vitamins and Used Primarily as Vitamins, Unmixed Derivatives (Exc. Vitamins A, B1, B2, B3, B5, B6, B12, C, E, H and Derivatives) in 2023 were China (US$12.2M), United States (US$6.5M), Switzerland (US$3.88M), India (US$3.55M), and France (US$1.24M).
In the global context, the main exporting countries of Its Vitamins and Used Primarily as Vitamins, Unmixed Derivatives (Exc. Vitamins A, B1, B2, B3, B5, B6, B12, C, E, H and Derivatives) in 2022 were China (US$591M), United States (US$258M), and Switzerland (US$247M). In the same year, the main importing countries of Its Vitamins and Used Primarily as Vitamins, Unmixed Derivatives (Exc. Vitamins A, B1, B2, B3, B5, B6, B12, C, E, H and Derivatives) were United States (US$289M), Germany (US$122M), and Netherlands (US$104M).
US$29.9M, Total Trade Exchange (2023)
In 2023, the total trade exchange of Its Vitamins and Used Primarily as Vitamins, Unmixed Derivatives (Exc. Vitamins A, B1, B2, B3, B5, B6, B12, C, E, H and Derivatives) in Mexico (including international purchases and sales) was US$29.9M.
The visualizations show the net balance of Its Vitamins and Used Primarily as Vitamins, Unmixed Derivatives (Exc. Vitamins A, B1, B2, B3, B5, B6, B12, C, E, H and Derivatives) at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
July, 2024: US$2.17M, International Purchases
In July 2024, international sales of Its Vitamins and Used Primarily as Vitamins, Unmixed Derivatives (Exc. Vitamins A, B1, B2, B3, B5, B6, B12, C, E, H and Derivatives) were US$0, while international purchases reached US$2.17M. The above results in a trade balance of -US$2.17M.
Jalisco: US$674k, State with the Most International Sales (2023)
Costa Rica: US$176k, Main commercial destination (2023)
In 2023, the states with the highest international sales in Its Vitamins and Used Primarily as Vitamins, Unmixed Derivatives (Exc. Vitamins A, B1, B2, B3, B5, B6, B12, C, E, H and Derivatives) were Jalisco (US$674k) and Estado de México (US$591).
In 2023, the countries with the most international purchases from Mexico were Costa Rica (US$176k), Dominican Republic (US$151k), El Salvador (US$147k), Guatemala (US$87.4k), and Colombia (US$38.2k).
Jalisco: US$21.4M, State with the Most International Purchases (2023)
China: US$12.2M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Its Vitamins and Used Primarily as Vitamins, Unmixed Derivatives (Exc. Vitamins A, B1, B2, B3, B5, B6, B12, C, E, H and Derivatives) were Jalisco (US$21.4M), Ciudad de México (US$1.89M), Estado de México (US$1.87M), Querétaro (US$1.57M), and Nuevo León (US$1.07M).
The countries with the most international sales to Mexico in 2023 were China (US$12.2M), United States (US$6.5M), Switzerland (US$3.88M), India (US$3.55M), and France (US$1.24M).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Its Vitamins and Used Primarily as Vitamins, Unmixed Derivatives (Exc. Vitamins A, B1, B2, B3, B5, B6, B12, C, E, H and Derivatives) and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Its Vitamins and Used Primarily as Vitamins, Unmixed Derivatives (Exc. Vitamins A, B1, B2, B3, B5, B6, B12, C, E, H and Derivatives). On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Its Vitamins and Used Primarily as Vitamins, Unmixed Derivatives (Exc. Vitamins A, B1, B2, B3, B5, B6, B12, C, E, H and Derivatives). In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Its Vitamins and Used Primarily as Vitamins, Unmixed Derivatives (Exc. Vitamins A, B1, B2, B3, B5, B6, B12, C, E, H and Derivatives) were China (US$591M), United States (US$258M), and Switzerland (US$247M). In the same year, the main importing countries for Its Vitamins and Used Primarily as Vitamins, Unmixed Derivatives (Exc. Vitamins A, B1, B2, B3, B5, B6, B12, C, E, H and Derivatives) were United States (US$289M), Germany (US$122M), and Netherlands (US$104M).